Sepsis News and Research

Latest Sepsis News and Research

Research provides new insights about when booster meningitis vaccines are needed

Scientists are indicating that children in Burkina Faso who were vaccinated against group A meningococcal meningitis and septicemia between the ages of 1-4 years in 2010, could need a booster dose of the vaccine as early as this year to ensure they remain protected.

27 Jul 2018

CNDA approves KEYTRUDA for treatment of advanced melanoma

Merck, known as MSD outside the United States and Canada, today announced that KEYTRUDA, Merck's anti-PD-1 therapy, has been approved by the China National Drug Administration for the treatment of adult patients with unresectable or metastatic melanoma following failure of one prior line of therapy.

26 Jul 2018

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Merck, known as MSD outside the United States and Canada, announced today that the pivotal Phase 3 KEYNOTE-048 trial investigating KEYTRUDA, Merck's anti-PD-1 therapy, for first-line treatment of recurrent or metastatic head and neck squamous cell carcinoma, met a primary endpoint of overall survival as monotherapy in patients whose tumors expressed PD-L1.

25 Jul 2018

Pediatric sepsis care within an hour increases chances of survival, shows study

More than one in 10 children hospitalized with sepsis die, but when a series of clinical treatments and tests is completed within an hour of its detection, the chances of survival increase considerably, according to a new analysis led by the University of Pittsburgh School of Medicine.

25 Jul 2018

New target for pneumonia seems to restore tight barriers and fluid clearance in the lungs

Severe pneumonia causes a buildup of fluid in the lungs that makes the basics of breathing and getting oxygen out to the body difficult to impossible.

25 Jul 2018

QUT researcher highlights growing impact of non-prescription antibiotics supply in pharmacies

With increased use of antibiotics worldwide linked to growing antibiotic resistance, a world-first study co-authored by a QUT researcher has highlighted the growing impact of non-prescription supply of antibiotics in community pharmacies, and the urgent need for better enforcement of laws.

20 Jul 2018

Bundled-payment system did not lower costs for serious medical conditions, shows study

A payment system that provides financial incentives for hospitals that reduce health-care costs for Medicare patients did not lower costs as intended, according to a new study led by Washington University School of Medicine in St. Louis.

19 Jul 2018

New guide helps hospitals pick right partner to handle hospitalist services

How to Pick a Partner to Manage Your Hospitalist Services is a helpful new guide to the questions hospitals should ask every candidate in order to determine the most qualified partner to manage their hospitalist services.

18 Jul 2018

Engineer patents cost-effective method to remove endotoxins from fluids

By some estimates, 18 million people die each year from sepsis triggered by endotoxins – fragments of the outer membranes of bacteria.

13 Jul 2018

Associate professor receives $1 million grant for disease research

Associate Professor Janelle Ayres is the recipient of a $1 million grant from the W. M. Keck Foundation to study new ways to treat deadly infections including sepsis and the flu, both of which require novel therapies beyond antibiotics and antivirals to effectively combat.

12 Jul 2018

Microfluidic chip to detect sepsis proves successful in clinical study

Two years after inventing a microfluidic chip believed to help detect a life-threatening blood infection, researchers in the Texas Tech University Department of Chemistry & Biochemistry and the Texas Tech University Health Sciences Center are finally seeing their product work successfully for human patients.

10 Jul 2018

Pneumococcal genes predict course of disease

Pneumococcus is an important cause of pneumonia, sepsis and meningitis. This bacterium commonly resides in the nasal cavity.

6 Jul 2018

New clues may lead to rapid detection of sepsis

Sepsis is an infection that kills as many Americans each year as stroke and Alzheimer's combined-about 250,000-but very little has changed in the treatment of this age-old scourge.

3 Jul 2018

Scoring system based on PIRO helps predict mortality in surgical ICU patients with severe sepsis

A new classification system that scores the variables associated with mortality rates for patients who develop intra-abdominal sepsis after surgery may help guide care and improve outcomes

2 Jul 2018

Dascena’s InSight system improves sepsis outcomes at Nacogdoches Memorial Hospital

Dascena, Inc. announces improved patient outcomes at Nacogdoches Memorial Hospital with the implementation InSight, a machine learning based algorithm for sepsis treatment.

2 Jul 2018

Streamlining and translating basic science discoveries into the clinic

To make sure that good ideas to enhance healthcare are not lost due to a lack of resources, a growing number of centers at Penn Medicine organize forums to pitch ideas to improve medical devices and technology, hold annual competitions to fund studies to improve patient care while keeping costs down, and sponsor seed grants for programs focused on patients who need individualized tailoring of their treatment.

2 Jul 2018

Scientists discover protein crucial for activating inflammation

Researchers from the University of Illinois at Chicago have identified a protein that is crucial for activating inflammation -; both the good kind of inflammation that leads to healing wounds and fighting infection, as well as excessive inflammation where the immune system can damage tissues and organs.

27 Jun 2018

Study reveals new way to inhibit capillary leakage in sepsis

Leakage from the blood capillaries is a key mechanism leading to septic shock and multiorgan failure, which affect millions of patients annually worldwide. However, there is no effective way to inhibit the vessel leakiness. A new study by scientists at the University of Helsinki and Wihuri Research Institute demonstrates that vascular leakage can be inhibited by targeting vascular integrins.

25 Jun 2018

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has accepted for standard review a new supplemental Biologics License Application for KEYTRUDA, Merck's anti-PD-1 therapy, as adjuvant therapy in the treatment of patients with resected, high-risk stage III melanoma and granted a Prescription Drug User Fee Act, or target action, date of February 16, 2019.

25 Jun 2018

Canakinumab reduces gout rate by more than half in atherosclerosis patients, study shows

The results of a study presented today at the Annual European Congress of Rheumatology (EULAR 2018) demonstrate that canakinumab significantly reduced the rate of gout by more than half compared to placebo, regardless of baseline serum urate level.

18 Jun 2018

Sepsis News and Research

Latest Sepsis News and Research

Research provides new insights about when booster meningitis vaccines are needed

CNDA approves KEYTRUDA for treatment of advanced melanoma

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Pediatric sepsis care within an hour increases chances of survival, shows study

New target for pneumonia seems to restore tight barriers and fluid clearance in the lungs

QUT researcher highlights growing impact of non-prescription antibiotics supply in pharmacies

Bundled-payment system did not lower costs for serious medical conditions, shows study

New guide helps hospitals pick right partner to handle hospitalist services

Engineer patents cost-effective method to remove endotoxins from fluids

Associate professor receives $1 million grant for disease research

Microfluidic chip to detect sepsis proves successful in clinical study

Pneumococcal genes predict course of disease

New clues may lead to rapid detection of sepsis

Scoring system based on PIRO helps predict mortality in surgical ICU patients with severe sepsis

Dascena’s InSight system improves sepsis outcomes at Nacogdoches Memorial Hospital

Streamlining and translating basic science discoveries into the clinic

Scientists discover protein crucial for activating inflammation

Study reveals new way to inhibit capillary leakage in sepsis

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Canakinumab reduces gout rate by more than half in atherosclerosis patients, study shows

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Sepsis News and Research

Latest Sepsis News and Research

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Newsletters you may be interested in